
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxQeTdsMjdkcFMxZzNQREIzenRBUVJOUnJ0c05FOVRadWZ3WXdnZV9tZ3VSVWJZU2MyZ0toQ1NReU9Nc09WUmswekM5c1RSaEdCVVlQMVZZckpacHZ4N0VqWjlDRWo5V2k2aTRnZS0ydW1Rem1LOEJMYkxYYlpKdjNuWUZCX1J0ZWZScEx3RF9ZVEd2SWFTcTFWT1RWWlNoenZjWDl3czhSQ2FTdHJ1dk92c3Q0UERrUllaWklTWE82cV84YVNxdF96OXJ5Tk1JY3R4cTE3ZnFFS1dfa3owRFk3clFMcVJheUV3M3pBaEo5YUdhMDdwYTZZZU9B?oc=5" target="_blank">Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>
